By a mile. Pretarget Lymphoma is peer reviewed fast track. With help from the NCI. No way STR, which will need to show survival ratings, will beat Lymphoma to market, it cannot.STR is YEARS away. Pretarget is moving fast and wide. Pretarget Lymphoma is our future.Funny thing though, everybody is trading Nerx and making money. I though the law of logic said that everyone cannot do it and make money. I am glad RAJA is so nimble...if they really are?
are you saying pretarget has fast tract with fda?